Kurt Fernstrom

Array ( [id] => 16176934 [patent_doc_number] => 20200223902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => PROCESS FOR PREPARING APOLIPOPROTEIN A-I (APO A-I) [patent_app_type] => utility [patent_app_number] => 16/575105 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15649699 [patent_doc_number] => 20200087379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 16/521789 [patent_app_country] => US [patent_app_date] => 2019-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18871187 [patent_doc_number] => 11858973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Granulysin, method of obtaining same, and uses [patent_app_type] => utility [patent_app_number] => 17/263122 [patent_app_country] => US [patent_app_date] => 2019-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 12104 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17005525 [patent_doc_number] => 20210236686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => SYNTHETIC HYDROGEL CARRIERS FOR MUSCLE REPAIR [patent_app_type] => utility [patent_app_number] => 17/263021 [patent_app_country] => US [patent_app_date] => 2019-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19472606 [patent_doc_number] => 12102669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Compositions for inhibiting teratoma formation and growth comprising TIMP-1 and TIMP-2 as effective components [patent_app_type] => utility [patent_app_number] => 17/274657 [patent_app_country] => US [patent_app_date] => 2019-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 4572 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17183850 [patent_doc_number] => 20210330735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF TRAUMATIC OPTIC NEUROPATHY [patent_app_type] => utility [patent_app_number] => 17/260718 [patent_app_country] => US [patent_app_date] => 2019-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -183 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17065847 [patent_doc_number] => 20210268062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => INFLAMMATORY SKIN DISORDER TREATMENT [patent_app_type] => utility [patent_app_number] => 17/255190 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9461 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15020763 [patent_doc_number] => 20190321386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events [patent_app_type] => utility [patent_app_number] => 16/452770 [patent_app_country] => US [patent_app_date] => 2019-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14993693 [patent_doc_number] => 20190315804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => PEPTIDES CAPABLE OF REACTIVATING p53 MUTANTS [patent_app_type] => utility [patent_app_number] => 16/451081 [patent_app_country] => US [patent_app_date] => 2019-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17193340 [patent_doc_number] => 11162083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => Peptide based inhibitors of Raf kinase protein dimerization and kinase activity [patent_app_type] => utility [patent_app_number] => 16/441054 [patent_app_country] => US [patent_app_date] => 2019-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 7879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15678439 [patent_doc_number] => 20200093883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => Use For JNK Inhibitor Molecules for Treatment of Various Diseases [patent_app_type] => utility [patent_app_number] => 16/430697 [patent_app_country] => US [patent_app_date] => 2019-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17120548 [patent_doc_number] => 11131675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => Peptides, devices, and methods for the detection of anaplasma antibodies [patent_app_type] => utility [patent_app_number] => 16/407565 [patent_app_country] => US [patent_app_date] => 2019-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28033 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 499 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16407565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15020895 [patent_doc_number] => 20190321452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE PROPHYLAXIS OF BPD [patent_app_type] => utility [patent_app_number] => 16/384994 [patent_app_country] => US [patent_app_date] => 2019-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15038523 [patent_doc_number] => 20190330266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE [patent_app_type] => utility [patent_app_number] => 16/380316 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19247 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14960735 [patent_doc_number] => 20190307845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => USE OF SYNTHETIC HISTONE-BINDING REGULATOR PROTEIN PcTF TO ACTIVATE SUPPRESSION OF CANCER CELL GROWTH [patent_app_type] => utility [patent_app_number] => 16/380544 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14960713 [patent_doc_number] => 20190307834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 16/376930 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9663 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14896953 [patent_doc_number] => 20190292242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => Hydrolyzed Jellyfish Collagen Types I, II, and V and Use Thereof [patent_app_type] => utility [patent_app_number] => 16/372798 [patent_app_country] => US [patent_app_date] => 2019-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14624581 [patent_doc_number] => 20190225658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => PEPTIBODIES, COMPOSITIONS THEREOF, AND METHODS OF TREATING ATRIAL FIBRILLATION [patent_app_type] => utility [patent_app_number] => 16/369822 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12801 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16369822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16596700 [patent_doc_number] => 20210023231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE [patent_app_type] => utility [patent_app_number] => 17/042039 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16755363 [patent_doc_number] => 10973891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Treatment and prevention of remote ischemia-reperfusion injury [patent_app_type] => utility [patent_app_number] => 16/359598 [patent_app_country] => US [patent_app_date] => 2019-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11968 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359598 [rel_patent_id] =>[rel_patent_doc_number] =>)